Clear IP and Adler Pollock & Sheehan P.C. Announce Collaboration to Offer Streamlined Provisional Patent Filing Service for MedTech Innovators

Image credit: Images supplied via Getty Images

Editorial Brief
At a glance: AI-assisted overview, optimised for journalists, search & news aggregators
Press Release

Dublin, Ireland & Providence, RI – December 17, 2025

Clear IP, a Dublin-based technology platform supporting idea capture and early-stage IP workflows, and Adler Pollock & Sheehan P.C. (AP&S), a leading U.S. law firm with extensive intellectual property experience, today announced a collaborative initiative offering MedTech innovators an efficient, structured approach to preparing and filing provisional patent applications.

The collaboration brings together Clear IP’s information-capture and workflow tools with AP&S’s established patent counseling and drafting capabilities, providing innovators with a clear option for securing an early filing date through an attorney-led process.

A Structured, Attorney-Led Pathway to Provisional Filing

Through the Clear IP platform, participating MedTech innovators will follow a coordinated process that includes:

  • Initial submission of core concepts and materials through the Clear IP platform
  • A scheduled consultation with an AP&S patent attorney
  • Attorney-supervised drafting of the provisional patent application
  • USPTO filing, following client review and approval

The offering includes attorney-prepared filing services from AP&S, together with a one-year professional license to the Clear IP innovation platform.

Supporting Innovators Seeking Clarity and Predictability

Early-stage MedTech teams frequently face uncertainty around timing, cost, and process. This collaborative service is designed to provide:

  • Predictable timelines from intake through filing
  • Transparent pricing and clearly defined steps
  • Consistency and quality, supported by Clear IP’s structured intake tools and AP&S’s MedTech-focused patent team

Securing an early filing date may help innovators advance conversations with investors, partners, and collaborators.

Quotes

Jim Joyce, Founder & CEO of Clear IP, said:
“MedTech innovators often need a clear and reliable path to securing an early patent filing. By combining Clear IP’s technology with AP&S’s established legal experience, we aim to provide a practical option that helps founders move forward confidently.”

Daniel Holmander, Shareholder at Adler Pollock & Sheehan P.C., commented:
“AP&S is committed to supporting innovators with thoughtful, forward-looking IP strategies. Collaborating with Clear IP enables us to work with founders through a platform designed to efficiently organize early-stage ideas, ultimately allowing us to deliver high-quality provisional filings in a timely and effective manner.”

Notes to editors

About Clear IP Clear IP is a technology platform that helps companies and innovators capture, organize, and develop ideas into intellectual property. Founded in 2024, Clear IP offers mobile and web-based tools, workflow features, and integrated services with legal professionals. More information: clearip.ai About Adler Pollock & Sheehan P.C. Founded in 1960, Adler Pollock & Sheehan P.C. (AP&S) is a full-service law firm with a strong intellectual property practice serving clients across the technology and MedTech sectors. The firm maintains offices in Boston, MA; Manchester, NH; New York City, NY; Newport, RI; and Providence, RI (100 Westminster Street, 16th Floor). Awards & Recognition AP&S and its attorneys have been recognized by:
  • Best Law Firms® (regional practice-area rankings)
  • The Best Lawyers in America®, including multiple “Lawyer of the Year” honorees
  • Best Lawyers: Ones to Watch® in America
  • Managing IP / IP Stars for patent and trademark practice
These distinctions reflect AP&S’s long-standing commitment to legal excellence and client service. More information: apslaw.com

Get more news like this

Get more news like this on Google. Set News By Wire as a ‘Preferred News Source’ to get quicker access to news that’s important.

All done!
Thank you for subscribing.

Email Subscription